Yibing R. Liu

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Redox-Modulated Polyoxometalate-Incorporated Carbazole-Based Interface for High-Performance Perovskite Photodetectors.

Redox-Modulated Polyoxometalate-Incorporated Carbazole-Based Interface for High-Performance Perovskite Photodetectors.

Journal: The journal of physical chemistry letters

Published: June 22, 2026

Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer (RERUN): Study Protocol for a Real-World, Multicenter, Prospective, Observational Study.

Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer (RERUN): Study Protocol for a Real-World, Multicenter, Prospective, Observational Study.

Journal: Advances in therapy

Published: May 15, 2026

Real-World Prognostic Analysis of Clinical Characteristics in Extensive-Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First-Line Immunochemotherapy With Serplulimab.

Real-World Prognostic Analysis of Clinical Characteristics in Extensive-Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First-Line Immunochemotherapy With Serplulimab.

Journal: Cancer medicine

Published: March 03, 2026

Multi-omics analysis identifies a major histocompatibility complex class II-associated antigen-presenting cancer-associated fibroblast-like state linked to the nuclear factor erythroid 2-related factor 2-karyopherin subunit beta 1 axis in nonsmall cell lung cancer.

Multi-omics analysis identifies a major histocompatibility complex class II-associated antigen-presenting cancer-associated fibroblast-like state linked to the nuclear factor erythroid 2-related factor 2-karyopherin subunit beta 1 axis in nonsmall cell lung cancer.

Journal: Journal of cell communication and signaling

Published: December 11, 2025

Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort study.

Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort study.

Journal: Translational cancer research

Published: August 13, 2025

Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma.

Nomogram-based risk stratification to analyze the value of receiving postoperative adjuvant therapy after neoadjuvant immunochemotherapy for patients with locally advanced esophageal squamous carcinoma.

Journal: Frontiers in immunology

Published: May 01, 2025

Exploiting underutilized heterogeneous data: A multi-source domain adaptive siamese network for few-shot bearing fault diagnosis.

Exploiting underutilized heterogeneous data: A multi-source domain adaptive siamese network for few-shot bearing fault diagnosis.

Journal: ISA transactions

Published: March 25, 2025

Case Report: Synchronous cervical, gastric and rectal metastases in occult breast cancer.

Case Report: Synchronous cervical, gastric and rectal metastases in occult breast cancer.

Journal: Frontiers in oncology

Published: March 24, 2025

Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546].

Corrigendum to "Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma". [Europ J Surg Oncol 51 (2025) 109546].

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 07, 2025

Prognostic roles of hematological indicators in programmed cell death protein 1/programmed cell death ligand 1 inhibitors for small-cell lung cancer: a retrospective cohort study.

Prognostic roles of hematological indicators in programmed cell death protein 1/programmed cell death ligand 1 inhibitors for small-cell lung cancer: a retrospective cohort study.

Journal: Journal of thoracic disease

Published: October 26, 2024

Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma.

Patterns of recurrence after esophagectomy following neoadjuvant immunochemotherapy in patients with thoracic esophageal squamous cell carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 01, 2024

Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database.

Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database.

Journal: Saudi medical journal

Published: February 03, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026